Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.

  Hepatitis C

  Free Subscription


2 Hepatology
1 J Gastroenterol
1 J Hepatol
1 J Med Virol
4 J Viral Hepat
3 PLoS One

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles


  1. LO RE V 3RD, Price JC, Schmitt S, Terrault N, et al
    The obstacle is the way: Finding a path to hepatitis C elimination.
    Hepatology. 2024 May 16. doi: 10.1097/HEP.0000000000000807.

  2. HALL EW, Bradley H, Barker LK, Lewis K, et al
    Estimating hepatitis C prevalence in the United States, 2017-2020.
    Hepatology. 2024 May 13. doi: 10.1097/HEP.0000000000000927.
    PubMed         Abstract available

    J Gastroenterol

  3. SUZUKI T, Matsuura K, Nagura Y, Ito K, et al
    MicroRNA-223-3p levels in serum-derived extracellular vesicles predict regression of M2BPGi-based liver fibrosis after hepatitis C virus eradication by direct-acting antiviral agents.
    J Gastroenterol. 2024 May 13. doi: 10.1007/s00535-024-02115.
    PubMed         Abstract available

    J Hepatol

  4. SHIHA G, Mikhail N, Soliman R
    Validation of SMART Model for HCC Risk stratification in genotype -4 HCV Patients following SVR and its comparison with GES score.
    J Hepatol. 2024 May 15:S0168-8278(24)00348-9. doi: 10.1016/j.jhep.2024.

    J Med Virol

  5. LIU CH, Chang YP, Lee JY, Chen CY, et al
    Four weeks of off-treatment follow-up is sufficient to determine virologic responses at off-treatment week 12 in patients with hepatitis C virus infection receiving fixed-dose pangenotypic direct-acting antivirals.
    J Med Virol. 2024;96:e29675.
    PubMed         Abstract available

    J Viral Hepat

  6. IRVIN R, Landry G, Jones MR, James A, et al
    High prevalence of hepatitis C virus infection among incarcerated persons: Results from the Louisiana Hepatitis C Elimination Plan's opt-out testing program in prisons.
    J Viral Hepat. 2024 May 17. doi: 10.1111/jvh.13941.
    PubMed         Abstract available

  7. MESZAROS M, Coursier S, Nagot N, Moulis L, et al
    Screening for hepatitis C virus at the time of mammography using rapid diagnostic tests in women aged between 50 and 74 years (Mamm'OC NCT05067374).
    J Viral Hepat. 2024 May 15. doi: 10.1111/jvh.13947.
    PubMed         Abstract available

  8. ROUSSOS S, Bagos C, Angelopoulos T, Chaikalis S, et al
    Incidence of primary hepatitis C infection among people who inject drugs during 2012-2020 in Athens, Greece.
    J Viral Hepat. 2024 May 14. doi: 10.1111/jvh.13951.
    PubMed         Abstract available

  9. ALQAHTANI SA, Yilmaz Y, El-Kassas M, Alswat K, et al
    Clinical and patient-reported outcomes in patients with chronic hepatitis B and C and non-alcoholic fatty liver disease from real-world practices in Saudi Arabia, Turkey and Egypt.
    J Viral Hepat. 2024 Apr 15. doi: 10.1111/jvh.13935.
    PubMed         Abstract available

    PLoS One

  10. HAGOS YM, Yalew GT, Meles HN, Tsegay E, et al
    Hepatitis B and C viral coinfection and associated factors among HIV-positive patients attending ART clinics of Afar regional state, northeast Ethiopia.
    PLoS One. 2024;19:e0302453.
    PubMed         Abstract available

  11. GOLAM RM, Khalil MAF, Shaker OG, Ahmed TI, et al
    The clinical significance of long non-coding RNAs MALAT1 and CASC2 in the diagnosis of HCV-related hepatocellular carcinoma.
    PLoS One. 2024;19:e0303314.
    PubMed         Abstract available

  12. PEWKLIANG Y, Thongsri P, Suthivanich P, Thongbaiphet N, et al
    Immortalized hepatocyte-like cells: A competent hepatocyte model for studying clinical HCV isolate infection.
    PLoS One. 2024;19:e0303265.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Hepatitis C is free of charge.